Retinal layer thickness linked to cognitive decline in older adults
May 27, 2022
Thinner baseline total macular retinal nerve fiber layer thickness was associated with a larger decline in cognitive function test scores during follow-up.
FDA OKs marketing of new test to help diagnose Alzheimer disease
May 06, 2022
The test is indicated for patients 55 years and older who present with cognitive impairment and are being evaluated for Alzheimer’s disease and cognitive decline.
Racial, ethnic disparities explored in subjective cognitive decline
Jul 08, 2021
More Black and Hispanic adults than white adults report subjective cognitive decline at age 45 to 54 years.
Yoga, meditation improve brain fitness: study
By
Lois A. Bowers
May 11, 2016
Yoga and meditation can offer a simple, safe and low-cost solution for improving brain fitness, according to new research. Combined, they were found to be even more effective than what many consider to...
Lumosity to pay $2 million to settle deceptive advertising charges
By
Lois A. Bowers
Jan 07, 2016
Lumosity has agreed to pay $2 million to settle Federal Trade Commission charges that it deceived consumers with unfounded claims that its “brain games” can reduce or delay cognitive impairment...
Should residents’ access to Alzheimer’s drug be restricted?
By
Lois A. Bowers
Jan 18, 2022
You have until Feb. 10 to share your comments with CMS about its recent proposal related to Alzheimer’s drug aducanumab (Aduhelm).
Virtual reality is more than entertainment for senior living residents
By
Chris Brickler
Mar 29, 2018
Virtual reality may hold the promise of delivering therapeutic benefits that possibly could reduce symptoms of diseases experienced by older adults, such as Alzheimer’s, Parkinson’s and macular...
‘Historic’ $100 million Alzheimer’s bill passes in House, heads to president’s desk
By
Lois A. Bowers
Dec 20, 2018
A bipartisan bill that authorizes $100 million in funding over five years to create a new public health infrastructure to combat Alzheimer’s disease is headed to the president’s desk after being passed...
Antipsychotic prescribing increases in assisted living during pandemic: study
By
Kimberly Bonvissuto
Apr 11, 2022
The prescribing of antipsychotic medications in assisted living communities and nursing homes has increased by 1.5% since the beginning of the COVID-19 pandemic, according to a recent study.
Higher habitual coffee intake may slow cognitive decline
Nov 30, 2021
Higher baseline coffee consumption also was linked to slower Aβ-amyloid accumulation during a 126-month study period, as shown on brain MRI scans.